Core Viewpoint - The company reported its 2024 annual results and 2025 Q1 results, showing a slight increase in revenue but a decline in net profit for 2024, while Q1 2025 showed growth in both revenue and net profit [1][3]. Group 1: Financial Performance - In 2024, the company achieved operating revenue of 892 million yuan, a year-on-year increase of 4.4%, and a net profit attributable to shareholders of 209 million yuan, a year-on-year decrease of 11.4% [1]. - For Q1 2025, the company reported operating revenue of 220 million yuan, a year-on-year increase of 1.8%, and a net profit attributable to shareholders of 56 million yuan, a year-on-year increase of 22.2% [1]. - The performance in 2024 and Q1 2025 met expectations, indicating a clear trend of recovery in the microscope sector [1]. Group 2: Business Segments - The optical microscope business generated sales revenue of 356 million yuan in 2024, a year-on-year decrease of 13.92%, influenced by industry demand recovery and equipment update policies, with a quarter-on-quarter sales increase of 8.53% in Q4 [1]. - The high-end microscope segment is experiencing rapid growth, achieving over 5% domestic substitution, with high-end microscopes accounting for approximately 40% of total microscope sales [1]. - The optical components business achieved sales revenue of 513 million yuan, a year-on-year increase of 22.56%, with barcode scanning business recovering quickly and LiDAR products reaching mass production, surpassing 100 million yuan in revenue [1]. Group 3: Research and Development - The company continued to invest in R&D, with expenditures reaching 98.5 million yuan in 2024, a year-on-year increase of 7.34%, representing 11.33% of main business revenue [2]. - The company launched several new microscopes priced between 200,000 and 3 million yuan, being one of the few domestic manufacturers capable of independently developing and producing super-resolution and confocal optical microscopes [2]. - The company has established long-term partnerships with several leading domestic clients in the semiconductor sector, with ultra-precision optical components already applied in maskless lithography equipment and semiconductor optical measurement devices [2]. Group 4: Profit Forecast and Valuation - The profit forecasts for 2025-2027 have been adjusted, with expected net profits of 302 million yuan, 349 million yuan, and 400 million yuan respectively, reflecting a downward revision for 2025-2026 due to the poor performance of the optical microscope business in 2024 [3]. - The current stock price corresponds to a price-to-earnings (PE) ratio of 32, 28, and 24 for 2025-2027, respectively, with the company being a leading optical manufacturer in China [3]. - The company is expected to continue enhancing its business scale and industry position, with a target PE of 42x for 2025, indicating over 20% upside potential from the current valuation [3].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a revenue of 892 million yuan for 2024, a year-on-year increase of 4.4%, and a net profit attributable to shareholders of 209 million yuan, a decrease of 11.4%. In Q1 2025, the company achieved a revenue of 220 million yuan, a year-on-year increase of 1.8%, and a net profit of 56 million yuan, a year-on-year increase of 22.2% [4][6] Financial Data and Profit Forecast - Total revenue for 2024 is projected at 892 million yuan, with a year-on-year growth rate of 4.4%. For Q1 2025, revenue is 220 million yuan, with a growth rate of 1.8%. The estimated revenues for 2025, 2026, and 2027 are 1,165 million yuan, 1,411 million yuan, and 1,673 million yuan respectively, with growth rates of 30.7%, 21.1%, and 18.5% [5][8] - The net profit attributable to shareholders for 2025 is estimated at 302 million yuan, with a growth rate of 45.0%. The projected net profits for 2026 and 2027 are 349 million yuan and 400 million yuan, with growth rates of 15.5% and 14.5% respectively [5][8] - The earnings per share for 2025 is estimated at 2.72 yuan, with a projected PE ratio of 32 [5][8] Business Performance Insights - The optical microscope business generated sales of 356 million yuan in 2024, a decline of 13.92%, while the optical components business achieved sales of 513 million yuan, an increase of 22.56%. The high-end microscope segment has seen significant growth, with over 5% domestic substitution achieved [6] - The company continues to invest in R&D, with expenditures reaching 98.5 million yuan in 2024, accounting for 11.33% of main business revenue. New microscope products priced between 200,000 and 3 million yuan have been launched, and the company has established long-term partnerships in the semiconductor sector [6] Profit Forecast Adjustments - The profit forecasts for 2025 and 2026 have been adjusted downwards, with new estimates for 2025 and 2026 net profits set at 302 million yuan and 349 million yuan respectively. The current stock price corresponds to PE ratios of 32, 28, and 24 for 2025, 2026, and 2027 respectively, indicating over 20% upside potential based on a target PE of 42 for 2025 [6]